HIV and Hepatitis B Coinfection: Disease progression, epidemiology, and liver transplantation.

 

        852. Inter- and Intra-genotypic Recombinations of HBV DNA in Subjects Coinfected by HIV

        914. The Long-term Use of Tenofovir Disoproxil in HIV-HBV Co-infection Induces a Marked Decrease in Liver Fibrosis.

        922. De Novo Combination Therapy of Tenofovir Disoproxil Fumarate (TDF) Plus Lamividine (LAM) or TDF Plus Emtricitabine (FTC) Is Associated with Early Virologic Response in HIV/HBV Co-infected Patients

        938. Entecavir Monotherapy Selects M184V Mutation in Lamivudine-nave and Lamivudine-experienced HIV-HBV Co-infected Patients

        954. Baseline CD4+ T Cell Count Predicts HBV Decline in HIV Negative and Positive and Patients Treated with Adefovir Dipivoxil

        967. Prior Lamivudine (LAM) Failure May Delay Time to Complete HBV-DNA Suppression in HIV Patients Treated with Tenofovir plus LAM